Evidence map›Paper›PMID 42137814›Full record

ArticleFrontiers in microbiology2026

Implications for safety:

Virginia Friedrichs, Sten Calvelage, Theresa Holzum, Elisenda Viaplana, Alicia Urniza, Monica Balasch, Martin Beer, Sandra Blome, Alexander Schäfer

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Virginia FriedrichsInstitute for Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Sten CalvelageInstitute for Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Theresa HolzumInstitute for Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Elisenda ViaplanaZoetis Manufacturing and Research Spain, Finca la Riba, L'Hostalnou de Bianya, Girona, Spain.
Alicia UrnizaZoetis Manufacturing and Research Spain, Finca la Riba, L'Hostalnou de Bianya, Girona, Spain.
Monica BalaschZoetis Manufacturing and Research Spain, Finca la Riba, L'Hostalnou de Bianya, Girona, Spain.
Martin BeerInstitute for Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Sandra BlomeInstitute for Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Alexander SchäferInstitute for Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

African swine fever poses an ongoing threat to Eurasian wild pigs and the associated global swine production, with no internationally licensed vaccine available. Live attenuated vaccines like

Indexed as

African swine fever virusbreeding boardomestic piggenetic stabilitylive attenuated vaccinesemen qualityvaccine safety

Identifiers

PMID42137814
PMCPMC13168198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.